XALACOM price in UAE

Overview

Welcome to Dwaey, specifically on XALACOM Eye Drops (Solution) page.
This medicine contains an important and useful components, as it consists of Latanoprost, Timolol (as maleate).
XALACOM is available in the market in concentration 50mcg, 5mg/ml and in the form of Eye Drops (Solution).

PHARMACIA N.V/S.A. is the producer of XALACOM and it is imported from BELGIUM, The most popular alternatives of XALACOM are listed downward .

Mode Of Action

Latanoprost is an analogue of prostaglandin F2alpha; it reduces intraocular pressure (IOP) by increasing outflow of aqueous humour. Timolol is a non-selective adrenergic blocker. It lowers IOP by decreasing the formation of aqueous by the ciliary epithelium.

Indication

Open-angle glaucoma
Ocular HTN

Precaution

Prolonged treatment with latanoprost may change eye colour by increasing the amount of brown pigment in the iris especially in patients with mixed coloured irides; regular eye examination is recommended. Caution when used in aphakic patients due to risk of macular oedema. Contact lenses should be removed during application and reinserted at least 15 minutes after application. May cause transient blurring of vision; patients should not drive or operate machinery until this resolves. Pregnancy and lactation.

Side Effects

>10% Ocular burning (11%) 1-10% Conjunctival hyperemia (9%)
Local itching
Tearing
Dry eye
Ocular discomfort
Increase in iris pigmentation (related to latanoprost)

Contra indication

Hypersensitivity.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks

Interaction

Additive effect on the intraocular pressure and other systemic effects may occur when used with oral beta-blockers, calcium channel blockers, guanethidine, antiarrhythmics, digitalis glycosides or parasympathomimetics. Concurrent use of >2 ophthalmic prostaglandin analogues may lead to paradoxical increase in intraocular pressure. Mydriasis may occur when used concurrently with epinephrine. beta-blocker may increase hypoglycaemic effect of antidiabetic agents.